fromWIRED1 week agoPatients Are Left With Few Options as GLP-1 Copycats DisappearAs the primary supply chain stabilizes, many are left without access to the compounded versions that had previously been their only option for weight loss medications.Alternative medicine
UK newsfromwww.independent.co.uk1 month agoBrexit costs denying NHS cancer patients life-saving drugs, report warnsBrexit is significantly hindering British cancer patients' access to new treatments and clinical trials.